医学新知2024,Vol.34Issue(12) :1417-1423.DOI:10.12173/j.issn.1004-5511.202408062

肠道菌群在脓毒症发生发展中的作用及其治疗潜力

The roles of the gut microbiome in the development and progression of sepsis and its therapeutic potential

李增亮 要旗 张开元 张利鹏
医学新知2024,Vol.34Issue(12) :1417-1423.DOI:10.12173/j.issn.1004-5511.202408062

肠道菌群在脓毒症发生发展中的作用及其治疗潜力

The roles of the gut microbiome in the development and progression of sepsis and its therapeutic potential

李增亮 1要旗 1张开元 1张利鹏1
扫码查看

作者信息

  • 1. 内蒙古医科大学附属医院重症医学科(呼和浩特 010000)
  • 折叠

摘要

脓毒症可导致患者免疫失调和多器官功能衰竭,全球范围内每年导致约1 100万人死亡,是重症监护病房最常见的死亡原因之一.肠道菌群(gut microbiome,GM)是人体重要的微生物组成部分,有助于维持全身免疫稳态,而GM失调可导致免疫防御功能缺陷,影响肠道屏障完整性,在脓毒症的发生发展中起着重要作用.GM具有丰富的遗传和代谢多样性,近年来在精准医疗和个体化治疗领域展现出广阔的应用前景.本文主要综述了 GM在脓毒症发生发展中的作用,并介绍了具有潜力的治疗方法,为通过调控GM以降低脓毒症发生风险、减少死亡率和改善预后提供了新的视角.

Abstract

Sepsis,which can lead to immune dysregulation and multiple organ dysfunction,causes approximately 11 million lives worldwide annually and is one of the most common causes of death in intensive care units.The gut microbiome,specifically referring to gut bacteria,is a crucial component of the human microbiota that contributes to systemic immune homeostasis.Dysbiosis,or an imbalance of the gut microbiota,can lead to impaired immune defense,compromised intestinal barrier integrity,and plays a pivotal role in the pathogenesis of sepsis.Given the gut microbiome's immense genetic and metabolic diversity,it has shown promising potential in precision medicine and personalized treatment.This review primarily summarized the impacts of the gut microbiome on the development of sepsis.It described potential therapeutic approaches,providing a new perspective for future research aimed at reducing the risk of sepsis,decreasing mortality rates,and improving patient outcomes by modulating the gut microbiome.

关键词

肠道菌群/脓毒症/菌群失调/治疗

Key words

Gut microbiome/Sepsis/Dysbiosis/Therapeutics

引用本文复制引用

出版年

2024
医学新知
武汉大学中南医院,中国农工民主党湖北省委医药卫生工作委员会

医学新知

CSTPCD
影响因子:0.243
ISSN:1004-5511
段落导航相关论文